Clinical Proteomics

Search for
Advanced search

Editor-in-Chief

  • Daniel Chan, Johns Hopkins University

Editorial Board | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

In 2011, Clinical Proteomics became a fully open access journal and is now published as part of BioMed Central's portfolio of journals. Clinical Proteomics welcomes new submissions; please check our instructions for authors for details of how to submit.

If you have any questions about the transition of the journal, please email journals@biomedcentral.com.

The journal's back content can be viewed here http://www.springerlink.com/content/120552/.

Aims & scope

Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts.

Editor's profile

Daniel W ChanDr Daniel W Chan is currently Professor of Pathology, Oncology, Urology, and Radiology at Johns Hopkins Medical Institutions, and Director of the Clinical Chemistry Division, Co-Director at the Pathology Core Laboratory, and Director at the Center for Biomarker Discovery at the Johns Hopkins University School of Medicine. He has worked extensively on the development and application of proteomic and immunologic techniques in the understanding of cancer. As the author of five books and over 200 articles, Dr Chan has become established as a leading expert in clinical proteomics and cancer research. Dr. Chan is an active member of Human Proteome Organization (HUPO) and its Plasma Proteome Initiative.

Submit a manuscript Register Sign up for article alerts

Email updates

Receive periodic news and updates relating to this journal.

Indexed by

  • Embase
  • Google Scholar
  • OCLC
  • PubMed
  • Scopus
  • Summon by Serial Solutions

View all

ISSN: 1559-0275